Epitor Therapeutics is an epigenetic editing company focused on developing novel tools to regulate gene expression that is under epigenetic control. Based in New York City, and with technology developed by Dr. Shawn Liu of Columbia University, the company focuses on further advancing these novel tools to control gene expression to treat diseases with high unmet needs. We are seeking highly motivated, self-driven individuals to join our team and help drive early-stage development.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3960 Broadway,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- New York, NY
Epitor Therapeutics Questions
Epitor Therapeutics's LinkedIn profile is https://www.linkedin.com/company/epitor
Epitor Therapeutics has
5 employees.
View email and phone details for 5
employees at Epitor Therapeutics.
Epitor Therapeutics's industry is
Biotechnology Research
Epitor Therapeutics's top competitors are
Somnum Pharma,
Orna Therapeutics,
Bluerock Therapeutics,
Ancilia Biosciences,
Aethon Therapeutics,
Scorpion Therapeutics,
Script Biosciences,
Regel Therapeutics,
Tfc Therapeutics,
Vertex Pharmaceuticals.
Epitor Therapeutics's categories are Biotechnology Research
Epitor Therapeutics's founding year is 2023
